Funding for Faculty

Additional Details

RFP Snapshot:  The Pancreatic Cancer Action Network Career Development Award represents an effort to encourage and support junior faculty to conduct pancreatic cancer research and establish successful career paths in this field. The grants provide $250,000 over two years for junior investigators that have yet to secure their first major research funding. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer. Special consideration will be given to understudied areas in pancreatic cancer research, minority researchers, and research focused on cancer health disparities.

Max Amount and Period: $250,000 over 2 years

Eligibility: At the start of the grant term on July 1, 2022, applicant must hold a faculty position with the title of Assistant Professor, Instructor, Research Assistant Professor or the equivalent and have completed their most recent doctoral degree within the past 11 years.

Due Date: October 25, 2021 at 11PM CST

Additional Details

RFP Snapshot:  Gateway focuses on transformational science via effective clinical trials—when basic science translates into human testing and clinical practice. We invest in Phase 1 and 2 clinical trials to enroll patients at all ages, with all cancer types, whose cancer is at any stage of progress—as long we they have the potential to help people live longer and feel better.

Max Amount and Period: $1.5M over 5 years

Eligibility: Researchers should be prepared to demonstrate how the proposed study fits with GFCR’s mission and focuses on one or more of the following therapeutic areas: New Investigational Therapies, Novel Use of Approach, Precision Medicine, Targeted Therapies.

Due Date: Letter of Intent Due: November 2, 2021 at 11:59PM CST

Additional Details

RFP Snapshot:  Gateway is focused on funding integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment. This also aims to increase quality of life, especially post-treatment.

Max Amount and Period: $1.5M over 5 years

Eligibility: Researchers should be prepared to demonstrate how the proposed study fits with GFCR’s mission and focuses on one or more of the following therapeutic areas: New Investigational Therapies, Novel Use of Approach, Precision Medicine, Targeted Therapies.

Due Date: Letter of Intent Due: November 2, 2021 at 11:59PM CST

 Companion Funding Opportunity: SIO Integrative Oncology Research Program Grant

Additional Details

RFP Snapshot: The Scholar (Career Development) Award is meant to help develop the independent research of highly qualified individuals still early in their careers. Recipients are called St. Baldrick’s Scholars. This is an early-career award. The Scholar award is intended to develop the independent pediatric cancer research careers of highly qualified investigators, not to support well established or senior investigators. Research projects must have direct applicability and relevance to pediatric cancer. They may be in any discipline of basic, clinical, translational, or epidemiological research.

Max Amount and Period: $220,000 over 2 years

Opportunity to apply for an additional three years of funding based upon the demonstration of significant accomplishment. Years 3–5, if funded, will be up to $115,000/year.

Eligibility: Applicants must currently hold (for no longer than 7 years at the time the award begins), or will hold by start of the award, a title that is considered by the institution to be a full-time, faculty position. Applicants holding or awarded R01s at the time of the LOI are not eligible to apply. Applicants cannot hold a NIH K-award at the time that they apply (institutional K12 funding is allowable). Scholar must devote at least 40% of effort to the funded project.

Due Date: INTERNAL: November 11^th, 2021 at 11:59PM CST

Important Note: One candidate from Washington University will move forward in the Scholar Award category. However, a second candidate may also be selected if the application meets the criteria of St. Baldrick’s limited submission policy exception.

Additional Details

RFP Snapshot: This award is intended to provide outstanding young physicians with the resources and training structure essential to becoming independent clinical investigators. The applicant is required to apply in conjunction with a mentor who is established in the field of clinical translational cancer research, cancer prevention, and/or epidemiology.

Max Amount and Period: $600,000 over 3 years

The fund will retire up to $100,000 of any medical school debt still owed by the awardee upon successful completion of the program.

Eligibility: Candidates must be U.S. citizens or permanent legal residents and must be within the first five years of initial full faculty appointment. The applicants must commit to spending 80% of their time conducting research. Candidates holding or awarded R01s at the time of the application are not eligible. No other physician-scientist mentored career development award from a private source may be held concurrently with this award.

Due Date: INTERNAL: November 11^th, 2021 at 11:59PM CST

Important Note: Five candidates (one per mentor) will move forward for the Clinical Investigator Award.

Additional Details

RFP Snapshot: The focus of the NCCN Foundation YIA is to identify and fund top investigators in the early stages of their careers, interested in participating and contributing to cancer care research and/or elucidating how the NCCN Guidelines are implemented in practice.

Max Amount and Period: $150,000 over 2 years

Eligibility: The award is open to physicians, scientists, nurses and others working in an oncology laboratory, clinical research or clinical setting, or cancer control program, who have a first full-time appointment as an Assistant Professor, Instructor, or an equivalent level, and are MD’s, PhD’s or, for nurses and others, have an advanced degree. Candidates must be in their first full-time appointment, and must not have other funding that duplicates the focus and purpose of this award. Applicants must have a mentor in the proposed research field, fully conversant in the clinical practice guidelines.

 Due Date: INTERNAL: November 11^th, 2021 at 11:59PM CST

Additional Details

RFP Snapshot: ALSF is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers. The Innovation Grant is designed to provide critical and significant seed funding for researchers with a novel approach to pediatric oncology scientific investigation. Proposals should have clinical translation in view. This may represent a change in research direction and/or an innovative new idea that moves away from an investigator’s prior research but for which a strong case is made for the potential impact on childhood cancers.

Max Amount and Period: $250,000 over 2 years

Eligibility: Applicants must have an MD, PhD, or MD/PhD or equivalent and be appointed as faculty (or equivalent) at an academic institution. Applicants must also have a track record of publication and funding productivity that demonstrates the project can be accomplished by the investigators.

Due Date: Letter of Intent Due: November 15, 2021 at 7PM CST

Additional Details

RFP Snapshot:  These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.

Max Amount and Period: $200,000 over 1-2 years

Eligibility: Prospective applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the Letter of Intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation.

Due Date: Letter of Intent Due: November 15, 2021 at 4PM CST

Additional Details

RFP Snapshot: This award encourages and supports early-stage clinical faculty with clinical and research responsibilities. The proposed project should be related to the applicant’s clinical activities, must directly involve patients or utilize patient samples, and may be in translational or clinical research with direct applicability and relevance to the understanding, detection, diagnosis, interception, treatment, or prevention of cancer.

Max Amount and Period: $375,000 over 3 years

Eligibility: Assistant Professors, Instructors, Research Assistant Professors or equivalent are eligible. Must be able to commit at least 50% of full-time effort in research. Eligibility is limited to members of racial or ethnic groups that have been shown to be underrepresented in the cancer related sciences, including but not limited to Blacks or African Americans, Hispanics or Latinos, Native Americans, Native Hawaiians, and other Pacific Islanders. Applicants must be active AACR members or have submitted a satisfactory application for membership by the deadline.

Due Date: November 30, 2021 at Noon CST

Additional Details

RFP Snapshot: This Award encourages and supports early-stage scientists engaged in cancer research. The proposed project may be in basic, translational, pre-clinical, or population sciences related research  and must have direct applicability and relevance to the understanding, detection, diagnosis, interception, treatment, or prevention of cancer.

Max Amount and Period: $300,000 over 3 years

Eligibility: Assistant Professors, Instructors, Research Assistant Professors or equivalent are eligible. Eligibility is limited to members of racial or ethnic groups that have been shown to be underrepresented in the cancer related sciences, including but not limited to Blacks or African Americans, Hispanics or Latinos, Native Americans, Native Hawaiians, and other Pacific Islanders. Applicants must be active AACR members or have submitted a satisfactory application for membership by the deadline.

Due Date: November 30, 2021 at Noon CST

Additional Details

RFP Snapshot: CLIP Grants provide funding for qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support pre-clinical and translational research, which will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.

Max Amount and Period: $200,000 over 2 years

Eligibility: Candidates for a CLIP Grant must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the Letter of Intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation. 

Due Date: Letter of Intent Due: December 1, 2021 at 4pm CST

Additional Details

RFP Snapshot: The research proposal needs to address issues on hematopoietic stem cell transplantation or cell therapy. Various aspects can be covered, including but not limited to: diagnostic and therapeutic strategies, transplant immunology, stem cell transplantation complications, donor selection or cell manufacturing.

Max Amount and Period: $283,000 over 3 years (award will be in Euros and exchanged to dollars)

Eligibility: Applicants must have obtained a doctorate, a PhD., MD or equivalent in a field relevant to the award within the last 8 years from the grant call start date (plus one year per child for mothers). Applicants do not need to hold a faculty position and can be in training (Fellows, Postdoctoral Fellows, and Junior Faculties).

Due Date: December 3, 2021